Northwest Clinical Center for Type 1 Diabetes - TrialNet

描述（由申请人提供）：本申请重新选择为糖尿病TrialNet临床中心，包括一份领导声明，概述了我们解决TrialNet当前挑战的观点和方法。它还描述了我们的临床中心为完成TrialNet的使命而开展的当前和计划的活动，包括合作和有效实现我们的总体目标-延迟和预防临床1型糖尿病发作的创新方法。TrialNet西北临床中心招募区域包括阿拉斯加、华盛顿、俄勒冈州、爱达荷州和蒙大拿州。我们与十几个附属网站，当地和区域T1 D倡导团体和糖尿病医疗保健提供者合作，以确保T1 D患者意识到他们的亲属有患病风险，并通过TrialNet进行沿着预防试验的可能性。我们还利用数字媒体，包括使用网站、Facebook、Twitter，开展大量招聘工作，以传达信息和促进讨论。我们地区有7500多人接受了风险筛查。TrialNet西北临床中心团队成员是TrialNet网络的积极参与者，并担任领导职务。我们计划在新的TrialNet结构中合作，以预防或延迟1型糖尿病。

DESCRIPTION (provided by applicant): This application for re-selection as a Diabetes TrialNet Clinical Center consists of a leadership statement outlining our perspective and approach to address TrialNet's current challenges. It also describes our Clinical Center's current and planned activities to accomplish TrialNet's mission including innovative approaches to collaboratively and efficiently achieving our overarching goal - delaying and preventing the onset of clinical type 1 diabetes. The TrialNet Northwest Clinical Center recruitment region encompasses Alaska, Washington, Oregon, Idaho, and Montana. We work with more than a dozen Affiliate sites, local and regional T1D advocacy groups and diabetes health care providers to assure that those with T1D are aware that their relatives are at risk for disease and that screening along with the possibility of prevention trials through TrialNet are available. We also have significant recruitment efforts using digital media, including the use of websites, Facebook, Twitter, to convey information and foster discussion. More than 7500 individuals in our region have been screened for risk. TrialNet Northwest Clinical Center team members are active participants and are in leadership roles in the TrialNet network. We plan to work collaboratively within the new TrialNet structure to prevent or delay type 1 diabetes.